Inventor · disambiguated record
Tiansen Li
Also filed as: LI TIANSEN
8 granted patents·1 pending application·52 citations·filing 2005–2020
83Inventor score
Files withMASSACHUSETTS EYE & EAR INFIRM4LI TIANSEN2MASSACHUSETTS EYE & EAR INFIRMARY2THE UNITED STATES OF AMERICANS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES1
Top patents by PatentIndex Score
9 records- 0193US7255856B2Lysyl oxidase-like 1 (LOXL1) and elastogenesisMASSACHUSETTS EYE & EAR INFIRM·Filed 2005·Granted Aug 14, 2007·25 cites·28 claims
- 0293US7255857B2Lysyl oxidase-like 1 (LOXL1) and elastogenesisMASSACHUSETTS EYE & EAR INFIRM·Filed 2005·Granted Aug 14, 2007·24 cites·30 claims
- 0374US8404231B2Lysyl oxidase-like 1 (LOXL1) and elastogenesisLI TIANSEN·Filed 2012·Granted Mar 26, 2013·2 cites·15 claims
- 0465US10314924B2RPGR gene therapy for retinitis pigmentosaMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2015·Granted Jun 11, 2019·1 cites·19 claims
- 0563US11045558B2RPGR gene therapy for retinitis pigmentosaMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2019·Granted Jun 29, 2021·0 cites·23 claims
- 0663US7674458B2Lysyl oxidase-like 1 (LOXL1) and elastogenesisMASSACHUSETTS EYE & EAR INFIRM·Filed 2007·Granted Mar 9, 2010·0 cites·28 claims
- 0758US11617801B2RP2 and RPGR vectors for treating X-linked retinitis pigmentosaTHE UNITED STATES OF AMERICANS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Apr 4, 2023·0 cites·19 claims
- 0852US8173121B2Lysyl oxidase-like 1 (LOXL1) and elastogenesisLI TIANSEN·Filed 2010·Granted May 8, 2012·0 cites·43 claims
- 0949US2014364488A1Rpgrip1 gene therapy for leber congenital amaurosisMASSACHUSETTS EYE & EAR INFIRM·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →